Quick Answer
Health Catalyst, Inc. reported Stockholders Equity of $245.78 million for the year ending 2025.
- Health Catalyst, Inc. showed a decrease of -32.7% in Stockholders Equity from 2024 to 2025.
- This data is from Health Catalyst, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$260.09 million | Q2 2018: -$282.61 million | Q3 2018: -$298.86 million | Q1 2019: -$450.04 million | Q2 2019: -$557.15 million | Q3 2019: $206.55 million | Q1 2020: $204.12 million | Q2 2020: $233.96 million | Q3 2020: $299.62 million | Q1 2021: $268.84 million | Q2 2021: $275.90 million | Q3 2021: $549.21 million | Q1 2022: $480.91 million | Q2 2022: $469.06 million | Q3 2022: $439.97 million | Q1 2023: $405.15 million | Q2 2023: $389.87 million | Q3 2023: $382.39 million | Q1 2024: $357.21 million | Q2 2024: $357.00 million | Q3 2024: $355.04 million | Q1 2025: $376.81 million | Q2 2025: $347.55 million | Q3 2025: $331.92 million.
- Over the full 10 years of available data (2016 to 2025), Health Catalyst, Inc.'s Stockholders Equity has grown by 219.1%.
- Historical annual values: Fiscal year 2025: $245.78 million | Fiscal year 2024: $365.21 million | Fiscal year 2023: $366.92 million | Fiscal year 2022: $425.01 million | Fiscal year 2021: $522.10 million | Fiscal year 2020: $276.10 million | Fiscal year 2019: $200.64 million | Fiscal year 2018: -$374.77 million | Fiscal year 2017: -$259.48 million | Fiscal year 2016: -$206.41 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: